These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 9811457)

  • 21. Protein tyrosine phosphatase epsilonC selectively inhibits interleukin-6- and interleukin- 10-induced JAK-STAT signaling.
    Tanuma N; Shima H; Nakamura K; Kikuchi K
    Blood; 2001 Nov; 98(10):3030-4. PubMed ID: 11698287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein-tyrosine phosphatase PTPepsilon C inhibits Jak-STAT signaling and differentiation induced by interleukin-6 and leukemia inhibitory factor in M1 leukemia cells.
    Tanuma N; Nakamura K; Shima H; Kikuchi K
    J Biol Chem; 2000 Sep; 275(36):28216-21. PubMed ID: 10859312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of suppressors of cytokine signaling (Socs) in leukemia inhibitory factor (LIF) -dependent embryonic stem cell survival.
    Duval D; Reinhardt B; Kedinger C; Boeuf H
    FASEB J; 2000 Aug; 14(11):1577-84. PubMed ID: 10928992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Negative regulation of cytokine signaling pathways.
    Yasukawa H; Sasaki A; Yoshimura A
    Annu Rev Immunol; 2000; 18():143-64. PubMed ID: 10837055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure and function of a new STAT-induced STAT inhibitor.
    Naka T; Narazaki M; Hirata M; Matsumoto T; Minamoto S; Aono A; Nishimoto N; Kajita T; Taga T; Yoshizaki K; Akira S; Kishimoto T
    Nature; 1997 Jun; 387(6636):924-9. PubMed ID: 9202127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of the activation status of Stat5a during LIF-induced differentiation of M1 myeloid leukemia cells.
    Piekorz RP; Rinke R; Gouilleux F; Neumann B; Groner B; Hocke GM
    Biochim Biophys Acta; 1998 Apr; 1402(3):313-23. PubMed ID: 9606990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A family of cytokine-inducible inhibitors of signalling.
    Starr R; Willson TA; Viney EM; Murray LJ; Rayner JR; Jenkins BJ; Gonda TJ; Alexander WS; Metcalf D; Nicola NA; Hilton DJ
    Nature; 1997 Jun; 387(6636):917-21. PubMed ID: 9202125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. gp130-Dependent signalling pathway is not enhanced in gp130 transgenic heart after LIF stimulation.
    Tone E; Kunisada K; Kumanogoh A; Negoro S; Funamoto M; Osugi T; Kishimoto T; Yamauchi-Takihara K
    Cytokine; 2000 Oct; 12(10):1512-8. PubMed ID: 11023666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell-specific pituitary gene expression profiles after treatment with leukemia inhibitory factor reveal novel modulators for proopiomelanocortin expression.
    Abbud RA; Kelleher R; Melmed S
    Endocrinology; 2004 Feb; 145(2):867-80. PubMed ID: 14576184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolactin-induced expression of cytokine-inducible SH2 signaling inhibitors in human hematopoietic progenitors.
    Cwikel S; Silvian-Drachsler I; Prolov L; Hooghe-Peters EL; Merchav S
    Exp Hematol; 2001 Aug; 29(8):937-42. PubMed ID: 11495699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thyrotropin induces SOCS-1 (suppressor of cytokine signaling-1) and SOCS-3 in FRTL-5 thyroid cells.
    Park ES; Kim H; Suh JM; Park SJ; Kwon OY; Kim YK; Ro HK; Cho BY; Chung J; Shong M
    Mol Endocrinol; 2000 Mar; 14(3):440-8. PubMed ID: 10707961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis.
    Shouda T; Yoshida T; Hanada T; Wakioka T; Oishi M; Miyoshi K; Komiya S; Kosai K; Hanakawa Y; Hashimoto K; Nagata K; Yoshimura A
    J Clin Invest; 2001 Dec; 108(12):1781-8. PubMed ID: 11748261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon regulatory factor 1 is a myeloid differentiation primary response gene induced by interleukin 6 and leukemia inhibitory factor: role in growth inhibition.
    Abdollahi A; Lord KA; Hoffman-Liebermann B; Liebermann DA
    Cell Growth Differ; 1991 Aug; 2(8):401-7. PubMed ID: 1793735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thyrotropin-mediated repression of class II trans-activator expression in thyroid cells: involvement of STAT3 and suppressor of cytokine signaling.
    Kim H; Suh JM; Hwang ES; Kim DW; Chung HK; Song JH; Hwang JH; Park KC; Ro HK; Jo EK; Chang JS; Lee TH; Lee MS; Kohn LD; Shong M
    J Immunol; 2003 Jul; 171(2):616-27. PubMed ID: 12847226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternative signaling mechanism of leukemia inhibitory factor responsiveness in a differentiating embryonal carcinoma cell.
    Takeda T; Kurachi H; Yamamoto T; Homma H; Adachi K; Morishige K; Miyake A; Murata Y
    Endocrinology; 1997 Jul; 138(7):2689-96. PubMed ID: 9202205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of IL-6-induced STAT3 tyrosine phosphorylation by TGF-beta1 is mediated by caspase-dependent and -independent processes.
    Wierenga AT; Schuringa JJ; Eggen BJ; Kruijer W; Vellenga E
    Leukemia; 2002 Apr; 16(4):675-82. PubMed ID: 11960349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-neuroendocrine interfacing.
    Bousquet C; Zatelli MC; Melmed S
    J Clin Invest; 2000 Dec; 106(11):1417-25. PubMed ID: 11104795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of interleukin-6, leukemia inhibitory factor and interferon-gamma on STAT DNA binding and c-fos mRNA levels in cortical astrocytes and C6 glioma cells.
    Jenab S; Quinones-Jenab V
    Neuro Endocrinol Lett; 2002 Aug; 23(4):325-8. PubMed ID: 12195235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. JAB/SOCS1/SSI-1 is an interleukin-2-induced inhibitor of IL-2 signaling.
    Sporri B; Kovanen PE; Sasaki A; Yoshimura A; Leonard WJ
    Blood; 2001 Jan; 97(1):221-6. PubMed ID: 11133764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SOCS3/CIS3 negative regulation of STAT3 in HGF-induced keratinocyte migration.
    Tokumaru S; Sayama K; Yamasaki K; Shirakata Y; Hanakawa Y; Yahata Y; Dai X; Tohyama M; Yang L; Yoshimura A; Hashimoto K
    Biochem Biophys Res Commun; 2005 Feb; 327(1):100-5. PubMed ID: 15629435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.